Eric E Adelman1, Phillip A Scott2, Lesli E Skolarus3, Allison K Fox2, Shirley M Frederiksen2, William J Meurer2. 1. Stroke Program, Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: eriadelm@med.umich.edu. 2. Department of Emergency Medicine, University of Michigan Medical School, Ann Arbor, Michigan. 3. Stroke Program, Department of Neurology, University of Michigan Medical School, Ann Arbor, Michigan.
Abstract
BACKGROUND:Protocol deviations before and after tissue plasminogen activator (tPA) treatment for ischemic stroke are common. It is unclear if patient or hospital factors predict protocol deviations. We examined predictors of protocol deviations and the effects of protocol violations on symptomatic intracerebral hemorrhage (sICH). METHODS: We used data from the Increasing Stroke Treatment through Interventional Behavior Change Tactics trial, a cluster-randomized, controlled trial evaluating the efficacy of a barrier assessment and educational intervention to increase appropriate tPA use in 24 Michigan community hospitals, to review tPA treatments between 2007 and 2010. Protocol violations were defined as deviations from the standard tPA protocol, both before and after treatment. Multilevel logistic regression models were fitted to determine if patient and hospital variables were associated with pretreatment or post-treatment protocol deviations. RESULTS: During the study, 557 patients (mean age 70, 52% male, median National Institutes of Health Stroke Scale score 12) were treated with tPA. Protocol deviations occurred in 233 (42%) patients: 16% had pretreatment deviations, 35% had post-treatment deviations, and 9% had both. The most common protocol deviations included elevated post-treatment blood pressure, antithrombotic agent use within 24 hours of treatment, and elevated pretreatment blood pressure. Protocol deviations were not associated with sICH, stroke severity, or hospital factors. Older age was associated with pretreatment protocol deviations (adjusted odds ratio [OR], .52; 95% confidence interval [CI], .30-.92). Pretreatment deviations were associated with post-treatment deviations (adjusted OR, 3.20; 95% CI, 1.91-5.35). CONCLUSIONS:Protocol deviations were not associated with sICH. Aside from age, patient and hospital factors were not associated with protocol deviations.
RCT Entities:
BACKGROUND: Protocol deviations before and after tissue plasminogen activator (tPA) treatment for ischemic stroke are common. It is unclear if patient or hospital factors predict protocol deviations. We examined predictors of protocol deviations and the effects of protocol violations on symptomatic intracerebral hemorrhage (sICH). METHODS: We used data from the Increasing Stroke Treatment through Interventional Behavior Change Tactics trial, a cluster-randomized, controlled trial evaluating the efficacy of a barrier assessment and educational intervention to increase appropriate tPA use in 24 Michigan community hospitals, to review tPA treatments between 2007 and 2010. Protocol violations were defined as deviations from the standard tPA protocol, both before and after treatment. Multilevel logistic regression models were fitted to determine if patient and hospital variables were associated with pretreatment or post-treatment protocol deviations. RESULTS: During the study, 557 patients (mean age 70, 52% male, median National Institutes of Health Stroke Scale score 12) were treated with tPA. Protocol deviations occurred in 233 (42%) patients: 16% had pretreatment deviations, 35% had post-treatment deviations, and 9% had both. The most common protocol deviations included elevated post-treatment blood pressure, antithrombotic agent use within 24 hours of treatment, and elevated pretreatment blood pressure. Protocol deviations were not associated with sICH, stroke severity, or hospital factors. Older age was associated with pretreatment protocol deviations (adjusted odds ratio [OR], .52; 95% confidence interval [CI], .30-.92). Pretreatment deviations were associated with post-treatment deviations (adjusted OR, 3.20; 95% CI, 1.91-5.35). CONCLUSIONS: Protocol deviations were not associated with sICH. Aside from age, patient and hospital factors were not associated with protocol deviations.
Authors: Atte Meretoja; Jukka Putaala; Turgut Tatlisumak; Sari Atula; Ville Artto; Sami Curtze; Olli Häppölä; Perttu J Lindsberg; Satu Mustanoja; Katja Piironen; Janne Pitkäniemi; Kirsi Rantanen; Tiina Sairanen; Oili Salonen; Heli Silvennoinen; Lauri Soinne; Daniel Strbian; Marjaana Tiainen; Markku Kaste Journal: Stroke Date: 2010-06-10 Impact factor: 7.914
Authors: Ken Uchino; Lori Massaro; Tudor G Jovin; Maxim D Hammer; Lawrence R Wechsler Journal: J Stroke Cerebrovasc Dis Date: 2010-06-17 Impact factor: 2.136
Authors: William J Meurer; Angela F Caveney; Alex Lo; Lingling Zhang; Shirley M Frederiksen; Annette M Sandretto; Robert Silbergleit; Phillip A Scott Journal: Stroke Date: 2010-08-05 Impact factor: 7.914
Authors: Phillip A Scott; Zhenzhen Xu; William J Meurer; Shirley M Frederiksen; Mary N Haan; Michael W Westfall; Sandip U Kothari; Lewis B Morgenstern; John D Kalbfleisch Journal: Stroke Date: 2010-08-12 Impact factor: 7.914
Authors: Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks Journal: Stroke Date: 2007-04-12 Impact factor: 7.914
Authors: Georgios Tsivgoulis; James L Frey; Murray Flaster; Vijay K Sharma; Annabelle Y Lao; Steven L Hoover; Wei Liu; Elefterios Stamboulis; Anne W Alexandrov; Marc D Malkoff; Andrei V Alexandrov Journal: Stroke Date: 2009-09-17 Impact factor: 7.914